Decheng Capital Management III (Cayman), LLC

Q3 2023 13F Holdings

Location
grand cayman, E9
Num holdings

26
Value ($000)

$299,635
Date Filed

12/12/2023
Form type

restatement
CIK

0001747821
All SEC filings
View on sec.gov
Note
Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers

Alpine Immune Sciences, Inc. 25.63%

Zentalis Pharmaceuticals Inc. 14.06%

Aura Biosciences, Inc. 6.09%

ROIVANT SCIENCES LTD 5.69%

ACELYRIN INC(NSM) 5.26%

Arcus Biosciences, Inc 5.21%

10x Genomics, Inc. 4.95%

Argenx SE 4.50%

Pacific Biosciences of California, Inc. 4.08%

Illumnia, Inc. 3.70%

LANTHEUS HOLDINGS INC(NMS) 3.30%

Horizon Therapeutics PLC 3.05%

PHATHOM PHARMACEUTICALS INC 2.94%

IMMUNOGEN INC 2.20%

SEAGEN INC 1.63%

Cue Health Inc. 1.32%

BeyondSpring Inc. 1.32%

Terns Pharmaceuticals, Inc. 1.20%

Equillium Inc. 1.10%

Aadi Bioscience, Inc. 0.85%

AtriCure Inc. 0.68%

Scynexis Inc. 0.42%

Mersana Therapeutics, Inc. 0.38%

Pyxis Oncology, Inc (formerly Apexigen) 0.22%

GeneDx Holdings Corp. 0.13%

Adicet Bio, Inc. 0.09%

Compare Q3 2023 to

Select Quarter

Issuer Name	Class	CUSIP	VALUE	%	Shares
ALPN ALPN Alpine Immune Sciences, Inc.	COM	02083G100	$76.81M	26 %	6,708,288
ZNTL ZNTL Zentalis Pharmaceuticals Inc.	COM	98943L107	$42.12M	14 %	2,099,583
AURA AURA Aura Biosciences, Inc.	COM	05153U107	$18.24M	6 %	1,163,123
--- ROIVANT SCIENCES LTD	COM	G76279101	$17.05M	6 %	1,459,700
--- ACELYRIN INC(NSM)	COM	00445A100	$15.75M	5 %	1,548,317
RCUS RCUS Arcus Biosciences, Inc	COM	03969F109	$15.61M	5 %	869,790
TXG TXG 10x Genomics, Inc.	CL A COM	88025U109	$14.83M	5 %	359,554
ARGX ARGX Argenx SE	SHS	04016X101	$13.48M	5 %	27,429
PACB PACB Pacific Biosciences of California, Inc.	COM	69404D108	$12.22M	4 %	1,463,872
ILMN ILMN Illumnia, Inc.	COM	452327109	$11.10M	4 %	80,859

Rows Per Page

1 - 10 of 26